Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2006

Open Access 01-12-2006 | Case report

Solitary pulmonary metastasis from primary melanoma of the oesophagus 5 years after resection of the primary tumor

Authors: Gianlorenzo Dionigi, Francesca Rovera, Luigi Boni, Andrea Imperatori, Renzo Dionigi

Published in: World Journal of Surgical Oncology | Issue 1/2006

Login to get access

Abstract

Background

Primary malignant melanoma of the oesophagus (PMME) is an uncommon tumor. PMME has an aggressive biological behavior, similar to melanomas developed elsewhere in the body. Most patients die from distant metastases, and the overall 5 year survival rate is approximately 4%.

Case presentation

We report a rare case of a solitary pulmonary metastasis found 5 years after curative resection of primary esophageal melanoma. No other sites of metastatic disease were identified. Video-assisted lung wedge resection of the lung nodule was carried out successfully.

Conclusion

This supports the concept that patients with primary melanoma of the oesophagus treated should be carefully followed up.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cadwell CB: Unusual malignant neoplasm of the esophagus. J Thorac Cardiovasc Surg. 1991, 101: 100-107. Cadwell CB: Unusual malignant neoplasm of the esophagus. J Thorac Cardiovasc Surg. 1991, 101: 100-107.
2.
go back to reference Baur EH: Ein Fall von primarem melanom des esophagus. Arb Geb Pathol Anat Inst Tubingen. 1906, 5: 343-354. Baur EH: Ein Fall von primarem melanom des esophagus. Arb Geb Pathol Anat Inst Tubingen. 1906, 5: 343-354.
3.
go back to reference De la Pava S, Nigogosyan G, Pickren JW, Cabrera A: Melanosis of the esophagus. Cancer. 1963, 16: 48-50.CrossRefPubMed De la Pava S, Nigogosyan G, Pickren JW, Cabrera A: Melanosis of the esophagus. Cancer. 1963, 16: 48-50.CrossRefPubMed
4.
go back to reference Tateshi R: Argyophil cells and melanocytes in esophageal mucosa. Arch Pathol. 1997, 98: 87-89. Tateshi R: Argyophil cells and melanocytes in esophageal mucosa. Arch Pathol. 1997, 98: 87-89.
5.
go back to reference Suzuki H, Nagayo T: Primary tumor of the esophagus other than squamous cell carcinoma: histological classification and statistics in the surgical and autopsied material in Japan. Int Adv Surg Oncol. 1980, 3: 73-109.PubMed Suzuki H, Nagayo T: Primary tumor of the esophagus other than squamous cell carcinoma: histological classification and statistics in the surgical and autopsied material in Japan. Int Adv Surg Oncol. 1980, 3: 73-109.PubMed
6.
go back to reference Di Costanzo DP, Urmacher C: Primary malignant melanoma of the esophagus. Am J Surg Pathol. 1987, 11: 46-52.CrossRef Di Costanzo DP, Urmacher C: Primary malignant melanoma of the esophagus. Am J Surg Pathol. 1987, 11: 46-52.CrossRef
7.
go back to reference Allen AC, Spitz S: Malignant melanoma: a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953, 6: 1-45.CrossRefPubMed Allen AC, Spitz S: Malignant melanoma: a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953, 6: 1-45.CrossRefPubMed
8.
go back to reference Sabanathan S, Eng J, Pradhan GN: Primary malignant melanoma of the esophagus. Am J Gastroenterol. 1989, 84: 1475-1481.PubMed Sabanathan S, Eng J, Pradhan GN: Primary malignant melanoma of the esophagus. Am J Gastroenterol. 1989, 84: 1475-1481.PubMed
9.
go back to reference Boni L, Benevento A, Dionigi G, Dionigi R: Primary malignant melanoma of the esophagus: a case report. Surg Endosc. 2002, 16: 359-360.CrossRefPubMed Boni L, Benevento A, Dionigi G, Dionigi R: Primary malignant melanoma of the esophagus: a case report. Surg Endosc. 2002, 16: 359-360.CrossRefPubMed
10.
go back to reference Boni L, Benevento A, Cabrini L, Dionigi G, Dionigi R: Primary melanoma of the esophagus. J Am Coll Surg. 2002, 194: 840-10.1016/S1072-7515(02)01168-7.CrossRefPubMed Boni L, Benevento A, Cabrini L, Dionigi G, Dionigi R: Primary melanoma of the esophagus. J Am Coll Surg. 2002, 194: 840-10.1016/S1072-7515(02)01168-7.CrossRefPubMed
11.
go back to reference Alexander P: Dormant metastases – studies in experimental animals. J Pathol. 1983, 141: 379-383. 10.1002/path.1711410314.CrossRefPubMed Alexander P: Dormant metastases – studies in experimental animals. J Pathol. 1983, 141: 379-383. 10.1002/path.1711410314.CrossRefPubMed
12.
go back to reference Lin CY: Primary malignant melanoma of the oesophagus presenting with massive melena and hypovolemic shock. ANZ J Surg. 2002, 72: 62-64. 10.1046/j.1445-2197.2002.02297.x.CrossRefPubMed Lin CY: Primary malignant melanoma of the oesophagus presenting with massive melena and hypovolemic shock. ANZ J Surg. 2002, 72: 62-64. 10.1046/j.1445-2197.2002.02297.x.CrossRefPubMed
13.
go back to reference Chalkiadakis G, Wihlm JM, Morand G, Weill-bousson M, Witz JP: Primary malignant melanoma of the esophagus. Ann Thorac Surg. 1985, 39: 472-475.CrossRefPubMed Chalkiadakis G, Wihlm JM, Morand G, Weill-bousson M, Witz JP: Primary malignant melanoma of the esophagus. Ann Thorac Surg. 1985, 39: 472-475.CrossRefPubMed
14.
go back to reference Salk D: Technetium-labeled monoclonal antibodies for imaging metastatic melanoma: results of a multicenter clinical study. Semin Oncol. 1988, 15: 608-618.PubMed Salk D: Technetium-labeled monoclonal antibodies for imaging metastatic melanoma: results of a multicenter clinical study. Semin Oncol. 1988, 15: 608-618.PubMed
15.
go back to reference Lamki LM, Zukiwski AA, Shanken LJ: Radioimaging of melanoma using 99 mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen. Cancer Res. 1990, 50: 904-908. Lamki LM, Zukiwski AA, Shanken LJ: Radioimaging of melanoma using 99 mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen. Cancer Res. 1990, 50: 904-908.
16.
17.
go back to reference Philip PA, Flaberty L: Treatment of malignant melanoma with interleukin-2. Semin Oncol. 1997, 24: S32-S38.PubMed Philip PA, Flaberty L: Treatment of malignant melanoma with interleukin-2. Semin Oncol. 1997, 24: S32-S38.PubMed
18.
go back to reference Rusciani L, Petraglia S, Alotto M, Calvieri S, Vezzoni G: Postsurgical adjuvant therapy for melanoma Evaluation of a 3-year randomized trial with recombinant interferon-alpha after 3 and 5 years of follow-up. Cancer. 1997, 79: 2354-2360. 10.1002/(SICI)1097-0142(19970615)79:12<2354::AID-CNCR9>3.0.CO;2-L.CrossRefPubMed Rusciani L, Petraglia S, Alotto M, Calvieri S, Vezzoni G: Postsurgical adjuvant therapy for melanoma Evaluation of a 3-year randomized trial with recombinant interferon-alpha after 3 and 5 years of follow-up. Cancer. 1997, 79: 2354-2360. 10.1002/(SICI)1097-0142(19970615)79:12<2354::AID-CNCR9>3.0.CO;2-L.CrossRefPubMed
19.
go back to reference Seigler HF, Lucas V, Pickett NJ: DTIC, CCNU, bleomycin and vincristine. Cancer. 1980, 46: 2346-2348.CrossRefPubMed Seigler HF, Lucas V, Pickett NJ: DTIC, CCNU, bleomycin and vincristine. Cancer. 1980, 46: 2346-2348.CrossRefPubMed
20.
go back to reference York RM, Foltz A: Bleomycin, vincristine, lomustine and DTIC chemotherapy for metastatic melanoma. Cancer. 1988, 61: 2183-2186.CrossRefPubMed York RM, Foltz A: Bleomycin, vincristine, lomustine and DTIC chemotherapy for metastatic melanoma. Cancer. 1988, 61: 2183-2186.CrossRefPubMed
21.
go back to reference Del Prete SA, Maurer LH, O'Donell J, Forcier RJ, LeMarbre P: Combination chemotherapy with cisplatin, carmustine, dacarbazine and tamoxifen in metastatic melanoma. Cancer Treat Rep. 1984, 68: 1403-1405.PubMed Del Prete SA, Maurer LH, O'Donell J, Forcier RJ, LeMarbre P: Combination chemotherapy with cisplatin, carmustine, dacarbazine and tamoxifen in metastatic melanoma. Cancer Treat Rep. 1984, 68: 1403-1405.PubMed
22.
go back to reference Mc Clay EF, Mastrange MJ, Berd D, Bellet RE: Effective combination chemo/hormonal therapy for malignant melanoma; experience with three consecutive trials. Int J Cancer. 1992, 50: 553-556.CrossRef Mc Clay EF, Mastrange MJ, Berd D, Bellet RE: Effective combination chemo/hormonal therapy for malignant melanoma; experience with three consecutive trials. Int J Cancer. 1992, 50: 553-556.CrossRef
23.
go back to reference Mills SE, Cooper PH: Malignant melanoma of the digestive system. Pathol Annu. 1983, 18: 1-26.PubMed Mills SE, Cooper PH: Malignant melanoma of the digestive system. Pathol Annu. 1983, 18: 1-26.PubMed
24.
go back to reference Saba HI, Cruse CW, Wells KE, Klein CJ, Reintgen DS: Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center study. Ann Plast Surg. 1992, 28: 65-69.CrossRefPubMed Saba HI, Cruse CW, Wells KE, Klein CJ, Reintgen DS: Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center study. Ann Plast Surg. 1992, 28: 65-69.CrossRefPubMed
25.
go back to reference Jawalekar K, Tretter P: Primary malignant melanoma of the esophagus. J Surg Oncol. 1979, 12: 19-25.CrossRefPubMed Jawalekar K, Tretter P: Primary malignant melanoma of the esophagus. J Surg Oncol. 1979, 12: 19-25.CrossRefPubMed
Metadata
Title
Solitary pulmonary metastasis from primary melanoma of the oesophagus 5 years after resection of the primary tumor
Authors
Gianlorenzo Dionigi
Francesca Rovera
Luigi Boni
Andrea Imperatori
Renzo Dionigi
Publication date
01-12-2006
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2006
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-4-22

Other articles of this Issue 1/2006

World Journal of Surgical Oncology 1/2006 Go to the issue